メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
川瀬 孝和
国際再生・免疫再生医学研究部門
h-index
3236
被引用数
34
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2005
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(75)
類似のプロファイル
(3)
フィンガープリント
Takakazu Kawaseが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Immunology and Microbiology
Bone Marrow Transplantation
100%
Human Leukocyte Antigen
87%
Acute Graft Versus Host Disease
86%
Allele
82%
Graft-Versus-Host Disease
78%
Transplant Procedure
57%
T Cell
54%
Cord Blood Stem Cell Transplantation
44%
Hematopoietic Cell
43%
Cell Transplantation
42%
Single Nucleotide Polymorphism
39%
Haplotype
33%
Chronic Graft Versus Host Disease
30%
Myeloid
27%
Overall Survival
25%
Allogeneic Bone Marrow Transplantation
25%
Conditioning
24%
T Cell Receptor
23%
Genetic Variability
23%
Allogeneic Stem Cell Transplantation
23%
Cyclophosphamide
22%
Aplastic Anemia
22%
Hematopoietic Stem Cell
22%
Interleukin 17
22%
Memory T Cell
22%
Stem Cell
20%
DNA Polymorphism
16%
Hematopoietic Stem Cell Transplantation
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Human T-Lymphotropic Virus 1
15%
Cytotoxic T Cell
15%
HLA DRB1 Antigen
12%
Ciclosporin
12%
Fc Receptor
11%
Haplotype Map
11%
Immune Repertoire
11%
Magnetic Resonance Imaging
11%
Methotrexate
11%
Genetic Association
11%
H Antigen
11%
Genotype Environment Interaction
11%
Apparent Diffusion Coefficient
11%
Streptococcus gallolyticus
11%
NOD2
11%
Tacrolimus
11%
CD180
11%
Multiple Myeloma
11%
Promoter Region
11%
Alternative RNA Splicing
11%
Granzyme B
11%
Medicine and Dentistry
Human Leukocyte Antigen
53%
Cancer Risk
46%
Odds Ratio
44%
Bone Marrow Transplantation
41%
Transplantation
36%
Case-Control Study
36%
Graft Versus Host Reaction
35%
Cell Transplantation
33%
Adult T-Cell Leukemia/Lymphoma
33%
Malignant Neoplasm
33%
Breast Cancer
33%
Hematopoietic Stem Cell
33%
Neoplasm
33%
Chronic Graft Versus Host Disease
30%
Disease
30%
Overall Survival
25%
T Cell
25%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
Allele
23%
Hazard Ratio
23%
Receptor
22%
Hematopoietic Stem Cell
22%
Allogenic Bone Marrow Transplantation
22%
Calcium Intake
22%
Cord Blood Stem Cell Transplantation
22%
Vitamin D
22%
Cord Blood
22%
Endometrial Cancer
22%
Multiple Myeloma
22%
Alcohol Consumption
20%
Acute Graft Versus Host Disease
19%
Magnetic Resonance Imaging
18%
Human T-Lymphotropic Virus 1
16%
Stem Cell
15%
T Lymphocyte Receptor
14%
Multivariate Analysis
14%
Leukemia
14%
Cyclophosphamide
13%
Single Nucleotide Polymorphism
12%
Chronic Myelogenous Leukemia
12%
Whole Body Radiation
12%
Allogeneic Stem Cell Transplantation
12%
Leukemia Relapse
11%
Fludarabine
11%
Retrospective Study
11%
Melphalan
11%
Penetrance
11%
Squamous Cell Carcinoma
11%
Lymphedema
11%
Aplastic Anemia
11%
Keyphrases
Unrelated Donor
33%
Graft-versus-host Disease (GvHD)
29%
Polymorphism
25%
Conditioning Regimen
23%
Bone Marrow Transplantation
23%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
23%
Japan
22%
Cyclophosphamide
20%
Lifestyle Factors
18%
Total Body Irradiation
17%
Risk Factors
16%
Single nucleotide Polymorphism
14%
Japan Marrow Donor Program
13%
Allogeneic Bone Marrow Transplantation
13%
Unrelated Bone Marrow Transplantation
13%
Adult Patients
12%
Body Mass Index
12%
Human Leukocyte antigen-A
12%
Rs6983267
11%
Microbe-microbe Interactions
11%
Host Microbiome
11%
Immune Repertoire Sequencing
11%
A2 Allele
11%
Haplotype Matching
11%
Prostate Stem Cell Antigen Gene
11%
Intron Polymorphism
11%
Endometrial Cancer
11%
Breast Cancer
11%
CYP19A1 Polymorphisms
11%
Highly Parallel
11%
Intronic SNP
11%
Pooled DNA
11%
Minor H Antigens
11%
8q24
11%
Similarity Matching
11%
Methotrexate
11%
Severe Aplastic Anemia
11%
Fibroblast Growth Factor Receptor 2 (FGFR2)
11%
Matched-pair Analysis
11%
Chemotherapy-induced Neutropenia
11%
Streptococcus Gallolyticus
11%
Reproductive Risk
11%
Dietary Calcium
11%
Stomach Cancer
11%
Adult T-cell Leukemia
11%
Incidence Risk
11%
Fat Fraction
11%
Body Diffusion
11%
MD-1
11%
CD180
11%
